InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by SPANA CARL, Chief Executive Officer. Director active across 1 companies, notably Palatin Technologies INC. In total, 12 disclosures have been published. Total volume traded: €67k. The latest transaction was disclosed on 9 December 2025 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations12 total
0110 shares0
Common Stock
SEC:0001493152-25-027269·
0110 shares0
Common Stock
SEC:0001493152-25-027269:0·
043,528 shares0
Common Stock
SEC:0001654954-22-008909:0·
0455,000 shares0
Common Stock
SEC:0001654954-22-008785:0·
€29,40661,628 shares@ €0.47720.45% mcap30.4% of flow
Common Stock
SEC:0001654954-21-008929·
€29,40661,628 shares@ €0.47720.45% mcap15.2% of flow
Common Stock
SEC:0001654954-21-008929:0·
€33,67564,400 shares@ €0.52290.52% mcap34.8% of flow
Common Stock
SEC:0001654954-21-007559·
Ideal exit: 27 Mar 2022 (T+270)
€33,67564,400 shares@ €0.52290.52% mcap17.4% of flow
Common Stock
SEC:0001654954-21-007559:0·
Ideal exit: 27 Mar 2022 (T+270)
€33,67564,400 shares@ €0.52290.52% mcap34.8% of flow
Common Stock
SEC:0001654954-21-007425·
€33,67564,400 shares@ €0.52290.52% mcap17.4% of flow
Common Stock
SEC:0001654954-21-007425:0·
0704,500 shares0
Common stock
SEC:0001654954-21-007251·
0704,500 shares0
Common stock
SEC:0001654954-21-007251:0·
12 of 12 declarations
About SPANA CARL
SPANA CARL serves as President and CEO of PALATIN TECHNOLOGIES INC. He leads the strategic and business operations of the company, focusing on innovation and the development of new treatments. With extensive experience in the biopharmaceutical sector, he is responsible for implementing growth strategies and optimizing company performance. SPANA plays a key role in creating value for shareholders.
